Cases & Deals

Share

North Coast invests in Cervilenz

August 2008

Client(s) North Coast Angel Fund

Jones Day advised North Coast Angel Fund in its purchase of Series A Convertible Preferred Stock in a private placement by CerviLenz Inc., a manufacturer and marketer of a patented, FDA-cleared device to predict preterm birth risk in pregnant women.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.